there will always be risk until the company can secure non dilutive funding.
At the moment this company cannot meet wages.
The options are limited, the most simple solution that they seem to use is to convert shareholder capital gains into wages.
rinse repeat
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4C - quarterly
AVR
anteris technologies global corp.
Add to My Watchlist
5.16%
!
$5.91

Ann: Appendix 4C - quarterly, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
0.290(5.16%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$5.79 | $6.19 | $5.79 | $17.15K | 2.906K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.10 | 170 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38 | 5.900 |
1 | 1000 | 5.850 |
1 | 500 | 5.600 |
1 | 3045 | 5.510 |
3 | 4281 | 5.500 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 100 | 1 |
6.400 | 450 | 2 |
6.550 | 1092 | 1 |
6.650 | 100 | 1 |
7.100 | 2000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online